WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Faculty

Axel Hauschild, MD, PhD

Professor of Dermatology
Clinic for Dermatology, Venerology and Allergology
University Hospital Schleswig-Holstein
Kiel, Germany

Disclosures

Axel Hauschild, MD, PhD, has the following financial relationships:
Consultant or advisor for: Amgen, Bristol-Myers Squibb, MS, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
Speaker or member of speakers bureau for: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
Research funding from: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
Contracted researcher for: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi

Nikhil Khushalani, MD

Vice Chair
Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL, United States

Disclosures

Nikhil Khushalani, MD, has the following financial relationships:
Consultant or advisor for: Bristol-Myers Squibb Company; Castle; Genzyme; Instill; Iovance; Jounce; Merck; NEKTAR; Novartis; Regeneron
Research funding from: Amgen; Bristol-Myers Squibb Company; Celgene; GlaxoSmithKline; HUYA; Merck; Novartis; Regeneron; Replimmune
Owns stock (publicly traded) in: Bellicum
Other: DSMB for AstraZeneca; Incyte; Steering Committee Member for NEKTAR; Pfizer; Regeneron

Editors

Mihai Surducan, PhD

Medical Education Director, Medscape, LLC

Disclosures

Mihai Surducan, PhD, has no relevant financial relationships.

Kathleen Krafton

Writer, Chichester Associates, Allendale, New Jersey

Disclosures

Kathleen Krafton has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CPD

Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?

Authors: Axel Hauschild, MD, PhD; Nikhil Khushalani, MD
CPD Released: 6/15/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 6/15/2023, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US oncologists, dermatologists, and pathologists.

The goal of this activity is that learners will be better able to assess, adhere to guidelines, and manage patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC).

Upon completion of this activity, participants will:

Have increased performance associated with
- Identifying patients with CSCC who are candidates for systemic therapy
- Prescribing the most appropriate therapy for CSCC patients
- Appropriately monitoring CSCC patients for adverse events

Disclosures

Faculty

Axel Hauschild, MD, PhD

Professor of Dermatology
Clinic for Dermatology, Venerology and Allergology
University Hospital Schleswig-Holstein
Kiel, Germany

Disclosures

Axel Hauschild, MD, PhD, has the following financial relationships:
Consultant or advisor for: Amgen, Bristol-Myers Squibb, MS, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
Speaker or member of speakers bureau for: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
Research funding from: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
Contracted researcher for: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi

Nikhil Khushalani, MD

Vice Chair
Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL, United States

Disclosures

Nikhil Khushalani, MD, has the following financial relationships:
Consultant or advisor for: Bristol-Myers Squibb Company; Castle; Genzyme; Instill; Iovance; Jounce; Merck; NEKTAR; Novartis; Regeneron
Research funding from: Amgen; Bristol-Myers Squibb Company; Celgene; GlaxoSmithKline; HUYA; Merck; Novartis; Regeneron; Replimmune
Owns stock (publicly traded) in: Bellicum
Other: DSMB for AstraZeneca; Incyte; Steering Committee Member for NEKTAR; Pfizer; Regeneron

Editors

Mihai Surducan, PhD

Medical Education Director, Medscape, LLC

Disclosures

Mihai Surducan, PhD, has no relevant financial relationships.

Kathleen Krafton

Writer, Chichester Associates, Allendale, New Jersey

Disclosures

Kathleen Krafton has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

For Physicians

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.0 continuing professional development credits (CPD).

Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

processing....

Transcrição em português

Download the pdf.

Download Now

&#160;

« Return to: Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?

PDF Downloads

Transcript Downloads

Print
Like Tweet

Faculty and Disclosures

Faculty

Axel Hauschild, MD, PhD

Nikhil Khushalani, MD

Editors

Mihai Surducan, PhD

Kathleen Krafton

Compliance Reviewer

Yaisanet Oyola, MD

Peer Reviewer

CPD

Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?

Target Audience and Goal Statement

Disclosures

Faculty

Axel Hauschild, MD, PhD

Nikhil Khushalani, MD

Editors

Mihai Surducan, PhD

Kathleen Krafton

Compliance Reviewer

Yaisanet Oyola, MD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?

Transcrição em português

PDF Downloads

Transcript Downloads